ROBERTS KENNETH D 4

Accession 0001178913-10-000304

CIK 0000793279other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 12:24 PM ET

Size

21.7 KB

Accession

0001178913-10-000304

Form 4

Period: 2010-01-05

Director

Transactions

Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−15,000→ 0 total
Exercise: $11.98Exp: 2014-01-29→ Common Stock, $0.01 par value per share (15,000 underlying)
Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−40,000→ 0 total
Exercise: $4.29Exp: 2018-01-25→ Common Stock, $0.01 par value per share (40,000 underlying)
Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−15,000→ 0 total
Exercise: $11.96Exp: 2014-01-26→ Common Stock, $0.01 par value per share (15,000 underlying)
Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−15,000→ 0 total
Exercise: $9.50Exp: 2015-02-11→ Common Stock, $0.01 par value per share (15,000 underlying)
Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−30,000→ 0 total
Exercise: $3.15Exp: 2013-01-27→ Common Stock, $0.01 par value per share (30,000 underlying)
Disposition to Issuer
Common Stock
2010-01-05−77,400→ 0 total
Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−30,000→ 0 total
Exercise: $15.33Exp: 2016-01-30→ Common Stock, $0.01 par value per share (30,000 underlying)
Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−30,000→ 0 total
Exercise: $3.33Exp: 2011-01-24→ Common Stock, $0.01 par value per share (30,000 underlying)

Footnotes (8)

[F1]These shares were disposed of pursuant to a merger agreement between the Issuer and Syneron Medical Ltd. ("Syneron") in exchange for 22,531 ordinary shares of Syneron having a market value of $10.39 per share at the close of trading on the effective date of the merger.
[F2]The stock-settled stock appreciation rights, which were exercisable in two equal annual installments beginning on January 25, 2009, were cancelled by Candela.
[F3]The non-qualified stock options, which were exercisable in two equal installments beginning on January 26, 2005, were cancelled by Candela.
[F4]The non-qualified stock options, which were exercisable in two equal installments beginning on January 29, 2005, were cancelled by Candela.
[F5]The non-qualified stock options, which were exercisable in one installment beginning on February 11, 2005, were cancelled by Candela.
[F6]The stock-settled stock appreciation rights, which were exercisable in two installments beginning on January 30, 2007, were cancelled by Candela.
[F7]The non-qualified stock options, which were exercisable in two equal installments beginning on January 27, 2004, were vested in full and assumed by Syneron as a result of the merger and replaced with non-qualified stock options to purchase 8,733 ordinary shares of Syneron at an exercise price of $10.83 per share.
[F8]The non-qualified stock options, which were exercisable in two equal installments beginning on January 24, 2002, were cancelled by Candela.

Documents

1 file

CANDELA CORP /DE/

CIK 0000793279

Entity typeother